Conseil Plus Gestion
6
2M
5
0.27
0.17
- Areas of investment
Summary
Conseil Plus Gestion appeared to be the Corporate Investor, which was created in 1999. The fund was located in Europe if to be more exact in France. The main office of represented Corporate Investor is situated in the Paris.
The important activity for fund was in 2016. The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 1 - 5 millions dollars.
Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - France. Among the most popular portfolio startups of the fund, we may highlight Therapixel. We can highlight the next thriving fund investment areas, such as Software, Medical Device.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Conseil Plus Gestion, startups are often financed by Demeter Partners, Paca Investissement, Sofimac Partners. The meaningful sponsors for the fund in investment in the same round are Paca Investissement, Sofimac Partners, IT-Translation. In the next rounds fund is usually obtained by Paca Investissement, Amundi Private Equity Funds, Sofimac Partners.
Investments analytics
Analytics
- Total investments
- 6
- Lead investments
- 0
- Rounds per year
- 0.27
- Follow on index
- 0.17
- Investments by industry
- Software (3)
- Wind Energy (2)
- Renewable Energy (2)
- Energy (2)
- Industrial (2) Show 12 more
- Investments by region
-
- France (6)
- Peak activity year
- 2016
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Therapixel | 24 Nov 2015 | Software, Artificial Intelligence, Health Diagnostics, Medical Device | Seed | 708K | France, Provence-Alpes-Côte d'Azur, Nice |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.